601607 上海医药
2026/06 - 中期
人民币(K¥)
与去年末期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)

非流动资产
长期股权投资6,965,584-0.64%7,010,2028,066,8458,351,9109,232,644
投资性房地产384,868-6.57%411,931366,010314,673246,415
固定资产15,292,222-1.30%15,493,39514,911,04512,155,05511,539,289
在建工程1,965,060-1.46%1,994,0942,148,6523,569,6292,777,363
无形资产8,498,379-2.81%8,743,7505,617,4626,050,8366,244,140
商誉12,652,944-0.10%12,665,61611,145,58611,393,33211,335,927
其他非流动资产6,628,9114.13%6,366,0837,130,7227,703,2367,246,253
52,387,968-0.56%52,685,07249,386,32349,538,67148,622,031

流动资产
货币资金36,572,96911.77%32,721,76335,744,32830,517,70627,401,396
应收账款90,767,87910.28%82,306,40179,129,20672,933,88166,759,854
存货42,684,986-5.90%45,358,94838,943,67036,623,39434,460,217
其他流动资产18,355,618-8.57%20,076,58418,005,90422,358,88120,891,404
188,381,4514.39%180,463,695171,823,107162,433,862149,512,871

流动负债
短期借款46,528,5165.53%44,091,82138,064,09935,560,50027,750,589
应付票据6,979,978-20.77%8,810,2069,241,1336,717,4445,961,724
应付帐款56,604,6727.63%52,594,35250,241,78747,915,01145,603,805
其他流动负债30,308,5772.04%29,701,72728,491,36732,178,92531,374,928
140,421,7433.86%135,198,106126,038,386122,371,879110,691,046
流动资产净值47,959,7075.95%45,265,58945,784,72140,061,98338,821,825
资产总额减流动负债100,347,6752.45%97,950,66095,171,04489,600,65587,443,855

非流动负债
长期借款3,277,067-22.64%4,235,8768,331,3345,786,1556,259,799
应付债券0--0000
其他非流动负债4,284,8289.10%3,927,4913,097,3463,488,4073,181,605
7,561,895-7.37%8,163,36711,428,6809,274,5629,441,404

总权益
    实收股本3,708,3620.00%3,708,3623,707,9723,703,3013,697,546
    储备项目74,639,5943.40%72,182,96667,967,64864,820,84263,365,460
股东权益78,347,9563.24%75,891,32871,675,62068,524,14367,063,006
非控股权益14,437,8243.90%13,895,96612,066,74411,801,95010,939,445